Open AccessNeoadjuvant pertuzumab, T-DM1, weekly paclitaxel and possible anthracyclines in HER2 positive early breast cancer treatment—questions from the KRISTINE study
Author(s) -
Jack P. Gleeson,
Niamh M. Keegan,
Patrick G. Morris
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.04.14
Subject(s) - pertuzumab , paclitaxel , oncology , breast cancer , medicine , cancer , biology , trastuzumab